WO2004037342A3 - Electrical stimulation of the brain - Google Patents

Electrical stimulation of the brain Download PDF

Info

Publication number
WO2004037342A3
WO2004037342A3 PCT/US2003/033305 US0333305W WO2004037342A3 WO 2004037342 A3 WO2004037342 A3 WO 2004037342A3 US 0333305 W US0333305 W US 0333305W WO 2004037342 A3 WO2004037342 A3 WO 2004037342A3
Authority
WO
WIPO (PCT)
Prior art keywords
brain
structures
stimulation
electrical stimulation
white matter
Prior art date
Application number
PCT/US2003/033305
Other languages
French (fr)
Other versions
WO2004037342A2 (en
Inventor
Jurgen Luders
Imad Najm
Hans O Luders
Original Assignee
Cleveland Clinic Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US42007902P priority Critical
Priority to US60/420,079 priority
Application filed by Cleveland Clinic Foundation filed Critical Cleveland Clinic Foundation
Publication of WO2004037342A2 publication Critical patent/WO2004037342A2/en
Publication of WO2004037342A3 publication Critical patent/WO2004037342A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/3606Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
    • A61N1/36082Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0526Head electrodes
    • A61N1/0529Electrodes for brain stimulation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0526Head electrodes
    • A61N1/0529Electrodes for brain stimulation
    • A61N1/0531Brain cortex electrodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0526Head electrodes
    • A61N1/0529Electrodes for brain stimulation
    • A61N1/0534Electrodes for deep brain stimulation

Abstract

The present invention relates electrical stimulation (18) of structures having high fiber density, such as white matter tracts (14) of the brain, to effect desired stimulation of associated brain structures. The stimulation of such white matter tracts or other structures can help reduce seizures or otherwise help control seizures by overdriving at least some electrical activity of the associated brain structures.
PCT/US2003/033305 2002-10-21 2003-10-20 Electrical stimulation of the brain WO2004037342A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US42007902P true 2002-10-21 2002-10-21
US60/420,079 2002-10-21

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2003286526A AU2003286526A1 (en) 2002-10-21 2003-10-20 Electrical stimulation of the brain
CA 2502455 CA2502455A1 (en) 2002-10-21 2003-10-20 Electrical stimulation of the brain
EP20030777727 EP1556127A2 (en) 2002-10-21 2003-10-20 Electrical stimulation of the brain

Publications (2)

Publication Number Publication Date
WO2004037342A2 WO2004037342A2 (en) 2004-05-06
WO2004037342A3 true WO2004037342A3 (en) 2004-07-01

Family

ID=32176513

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/033305 WO2004037342A2 (en) 2002-10-21 2003-10-20 Electrical stimulation of the brain

Country Status (4)

Country Link
EP (1) EP1556127A2 (en)
AU (1) AU2003286526A1 (en)
CA (1) CA2502455A1 (en)
WO (1) WO2004037342A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8855775B2 (en) 2006-11-14 2014-10-07 Cyberonics, Inc. Systems and methods of reducing artifact in neurological stimulation systems
US9289595B2 (en) 2009-01-09 2016-03-22 Cyberonics, Inc. Medical lead termination sleeve for implantable medical devices
US9445730B2 (en) 2007-03-21 2016-09-20 Cyberonics, Inc. Implantable systems and methods for identifying a contra-ictal condition in a subject

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8762065B2 (en) 1998-08-05 2014-06-24 Cyberonics, Inc. Closed-loop feedback-driven neuromodulation
US7209787B2 (en) 1998-08-05 2007-04-24 Bioneuronics Corporation Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US9375573B2 (en) 1998-08-05 2016-06-28 Cyberonics, Inc. Systems and methods for monitoring a patient's neurological disease state
US7853329B2 (en) 1998-08-05 2010-12-14 Neurovista Corporation Monitoring efficacy of neural modulation therapy
US9415222B2 (en) 1998-08-05 2016-08-16 Cyberonics, Inc. Monitoring an epilepsy disease state with a supervisory module
US7747325B2 (en) 1998-08-05 2010-06-29 Neurovista Corporation Systems and methods for monitoring a patient's neurological disease state
US9042988B2 (en) 1998-08-05 2015-05-26 Cyberonics, Inc. Closed-loop vagus nerve stimulation
US20080070267A1 (en) * 2004-05-20 2008-03-20 The Regents Of The University Of California Modulation Of Neurotransmitter Activity In Neurons
US8725243B2 (en) 2005-12-28 2014-05-13 Cyberonics, Inc. Methods and systems for recommending an appropriate pharmacological treatment to a patient for managing epilepsy and other neurological disorders
US8868172B2 (en) 2005-12-28 2014-10-21 Cyberonics, Inc. Methods and systems for recommending an appropriate action to a patient for managing epilepsy and other neurological disorders
WO2007150003A2 (en) 2006-06-23 2007-12-27 Neurovista Corporation Minimally invasive monitoring systems and methods
US9898656B2 (en) 2007-01-25 2018-02-20 Cyberonics, Inc. Systems and methods for identifying a contra-ictal condition in a subject
WO2008092133A2 (en) 2007-01-25 2008-07-31 Neurovista Corporation Methods and systems for measuring a subject's susceptibility to a seizure
US8340770B2 (en) 2007-06-26 2012-12-25 Durand Dominique M Controlling seizure activity with electrical stimulation
US9788744B2 (en) 2007-07-27 2017-10-17 Cyberonics, Inc. Systems for monitoring brain activity and patient advisory device
US9259591B2 (en) 2007-12-28 2016-02-16 Cyberonics, Inc. Housing for an implantable medical device
US8849390B2 (en) 2008-12-29 2014-09-30 Cyberonics, Inc. Processing for multi-channel signals
US8786624B2 (en) 2009-06-02 2014-07-22 Cyberonics, Inc. Processing for multi-channel signals
US9643019B2 (en) 2010-02-12 2017-05-09 Cyberonics, Inc. Neurological monitoring and alerts

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6366813B1 (en) * 1998-08-05 2002-04-02 Dilorenzo Daniel J. Apparatus and method for closed-loop intracranical stimulation for optimal control of neurological disease

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6366813B1 (en) * 1998-08-05 2002-04-02 Dilorenzo Daniel J. Apparatus and method for closed-loop intracranical stimulation for optimal control of neurological disease

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8855775B2 (en) 2006-11-14 2014-10-07 Cyberonics, Inc. Systems and methods of reducing artifact in neurological stimulation systems
US9445730B2 (en) 2007-03-21 2016-09-20 Cyberonics, Inc. Implantable systems and methods for identifying a contra-ictal condition in a subject
US9289595B2 (en) 2009-01-09 2016-03-22 Cyberonics, Inc. Medical lead termination sleeve for implantable medical devices

Also Published As

Publication number Publication date
EP1556127A2 (en) 2005-07-27
CA2502455A1 (en) 2004-05-06
AU2003286526A1 (en) 2004-05-13
WO2004037342A2 (en) 2004-05-06

Similar Documents

Publication Publication Date Title
TWI283164B (en) Anthranilamide arthropodicide treatment
JO2764B1 (en) Indole derivatives or benzimidazole derivatives for modulating ikappab kinase
TWI259080B (en) Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment
PL215542B1 (en) Disubstituted pyrazolyl carboxanilides
BRPI0412918A (en) p38 kinase inhibitors
WO2007120980A3 (en) 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
CA2476012A1 (en) Substituted pyridinones as modulators of p38 map kinase
AU3984001A (en) System and method for preventing sudden cardiac death by nerve sprouting from right stellate ganglion
PL216744B1 (en) Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
BG108598A (en) Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as ppar activators
RU2008146718A (en) Methods of treating neurological conditions with the use of hematopoietic growth factors
MXPA05005814A (en) Pyrazole and imidazole compounds and uses thereof.
MXPA06004854A (en) 2-halogen-6-alkyl-phenyl substituted tetramic acid derivatives.
WO2003084477A3 (en) Mammalian cdr mimetibodies, compositions, methods and uses
TW200526650A (en) Isoquinoline derivatives
SI1429761T1 (en) Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
WO2001034646A3 (en) Recombinant gelatins
WO2003051833A3 (en) Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5
WO2005012242A3 (en) Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides
WO2003029264A3 (en) 2-propynyl adenosine analogs having a2a agonist activity and compositions thereof
AU2002256690A1 (en) 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity
WO2003048324A3 (en) Antisense modulation of phospholipid scramblase 3 expression
WO2005002626A3 (en) Therapeutic phosphonate compounds
EA014685B1 (en) Phosphonate-containing antiviral compounds (variants) and pharmaceutical composition based thereon
MXPA05000130A (en) Aryl carbonyl derivatives as therapeutic agents.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2502455

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2003286526

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2003777727

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003777727

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2003777727

Country of ref document: EP

NENP Non-entry into the national phase in:

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP